|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61P 25/00 | (2006.01) |
| C07D 207/27 | (2006.01) | ||
| A61K 31/4015 | (2006.01) | ||
| A61P 25/02 | (2006.01) | ||
| A61P 25/24 | (2006.01) | ||
| A61P 25/28 | (2006.01) |
| (11) | Number of the document | 3890833 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19813837.2 |
| Date of filing the European patent application | 2019-12-04 | |
| (97) | Date of publication of the European application | 2021-10-13 |
| (45) | Date of publication and mention of the grant of the patent | 2023-06-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2019/083594 |
| Date | 2019-12-04 |
| (87) | Number | WO 2020/115093 |
| Date | 2020-06-11 |
| (30) | Number | Date | Country code |
| 18210106 | 2018-12-04 | EP |
| (72) |
FARINA, Carlo , IT
SCHERZ, Michael , CH
GHELARDINI, Carla , IT
DI CESARE MANNELLI, Lorenzo , IT
|
| (73) |
Metys Pharmaceuticals AG ,
Gerbergasse 30, 4001 Basel,
CH
|
| (54) | SYNERGISTIC COMPOSITIONS COMPRISING (R)-2-(2-OXOPYRROLIDIN-1-YL)BUTANAMIDE AND (S)-2-(2-OXOPYRROLIDIN-1-YL)BUTANAMIDE IN A NON-RACEMIC RATIO |
| SYNERGISTIC COMPOSITIONS COMPRISING (R)-2-(2-OXOPYRROLIDIN-1-YL)BUTANAMIDE AND (S)-2-(2-OXOPYRROLIDIN-1-YL)BUTANAMIDE IN A NON-RACEMIC RATIO |